
Arvinas Holding Company ($ARVN) announced an update on their ongoing clinical study. Arvinas Inc. is evaluating ARV-806 in the study titled “A Phase 1/2 Clinical Trial to Evaluate the Safety,
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| ARVN | Arvinas Holding Company | 6.61 | -4.20 | -38.84% |
| Name | Price | % Change | |
|---|---|---|---|
| $6.61 | -38.84% |

Arvinas Holding Company ($ARVN) announced an update on their ongoing clinical study. Arvinas Inc. is evaluating ARV-806 in the study titled “A Phase 1/2 Clinical Trial to Evaluate the Safety,

Arvinas Holding Company (($ARVN)) has held its Q3 earnings call. Read on for the main highlights of the call. Arvinas delivered a predominantly positive earnings call, highlighting progress across oncology

BofA lowered the firm’s price target on Arvinas (ARVN) to $15 from $16 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for

Arvinas Holding Company (ARVN) has disclosed a new risk, in the Technology category. Arvinas Holding Company’s growing reliance on AI and machine learning across its PROTAC Discovery Engine and related

Analyst Jeet Mukherjee of BTIG maintained a Buy rating on Arvinas Holding Company, retaining the price target of $18.00. Jeet Mukherjee has given his Buy rating due to a combination

16:42 EST Arvinas (ARVN) files $400M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended

H.C. Wainwright lowered the firm’s price target on Arvinas (ARVN) to $13 from $18 and keeps a Buy rating on the shares. The firm says Arvinas’ Q3 update puts the

Arvinas Holding Company ( ($ARVN) ) has provided an update. On November 3, 2026, Arvinas reported third-quarter results and a corporate update. During the quarter, it initiated patient dosing in

Reports Q3 revenue $500,000, consensus $16.93M. “We executed strongly during the quarter and are entering an important period of clinical milestones that we believe will demonstrate the promise of our

Arvinas Holding Company (ARVN) is scheduled to report 3rd quarter earnings on 11/03/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Arvinas Holding Company to post earnings
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Assigned | Nov 6, 2026 | ||||
| hold | Reiterated | Nov 6, 2026 | ||||
| hold | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 4, 2026 | ||||
| hold | Reiterated | Nov 4, 2026 | ||||
| buy | Reiterated | Nov 3, 2026 | ||||
| hold | Assigned | Aug 10, 2026 | ||||
| buy | Reiterated | Aug 10, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 1, 2027TBA | $441.37M | $-0.71 | $11.85M | 0.17 | -44.93 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.